Anthraquinone derivative emodin inhibits tumour-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation

Kaneshiro T et al. European Journal of Pharmacology. Volume 553, Issues 1-3, 28 December 2006, Pages 46-53 doi:10.1016/j.ejphar.2006.09.026 An anthraquinone derivative, emodin, suppresses tumor development both in vitro and in vivo. In this study, we examined the anti-angiogenic activity of emodin and its modifying effect on the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. In […]

read more